The Food and Drug Administration (FDA) has expanded its approval of a ketamine nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

Spravato (esketamine) is prescribed for adults to treat: major depressive disorder (MDD), also called depression, with suicidal thoughts or actions treatment-resistant depression For MDD ...

In terms of the newest collaboration, the health care professionals said they decided that having all the services under one ...

The Food and Drug Administration (FDA) has not approved ketamine as a treatment for any psychiatric disorder. The only FDA-approved option is Spravato, a nasal spray made from a derivative of ...

So SPRAVATO is indicated for treatment resistant depression. It is esketamine. It's a single enantiomer of ketamine. It's an intranasally administered compound. It was approved in 2019 for ...

Blessing Outpatient Behavioral Health Services is offering a new option for depression. As many as 40% of people with depression can find no relief for their condition.

My practice is integrated care for adults (psychiatric medication management, psychedelic esketamine (Spravato) treatments, primary care, weight loss injection therapy and asthetics). I am board ...

TMS and Spravato Our compassionate team is committed to providing a safe, supportive environment where you can explore your treatment options and find the best path forward. Whether you’re ...